DK3749669T6 - Ahr-modulatorer - Google Patents

Ahr-modulatorer Download PDF

Info

Publication number
DK3749669T6
DK3749669T6 DK19706135.1T DK19706135T DK3749669T6 DK 3749669 T6 DK3749669 T6 DK 3749669T6 DK 19706135 T DK19706135 T DK 19706135T DK 3749669 T6 DK3749669 T6 DK 3749669T6
Authority
DK
Denmark
Prior art keywords
ahr modulators
ahr
modulators
Prior art date
Application number
DK19706135.1T
Other languages
Danish (da)
English (en)
Other versions
DK3749669T3 (da
Inventor
Muzaffar Alam
Hilary Plake Beck
Michael Patrick Dillon
Marcos Gonzalez-Lopez
James Clifford Sutton Jr
Original Assignee
Ideaya Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ideaya Biosciences Inc filed Critical Ideaya Biosciences Inc
Publication of DK3749669T3 publication Critical patent/DK3749669T3/da
Application granted granted Critical
Publication of DK3749669T6 publication Critical patent/DK3749669T6/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
DK19706135.1T 2018-02-06 2019-02-05 Ahr-modulatorer DK3749669T6 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862626739P 2018-02-06 2018-02-06
US201962793260P 2019-01-16 2019-01-16
PCT/US2019/016705 WO2019156987A1 (en) 2018-02-06 2019-02-05 AhR MODULATORS

Publications (2)

Publication Number Publication Date
DK3749669T3 DK3749669T3 (da) 2023-06-06
DK3749669T6 true DK3749669T6 (da) 2024-11-18

Family

ID=65494575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19706135.1T DK3749669T6 (da) 2018-02-06 2019-02-05 Ahr-modulatorer

Country Status (10)

Country Link
US (3) US10815250B2 (enExample)
EP (2) EP4219495A1 (enExample)
JP (1) JP7382348B2 (enExample)
CN (1) CN111683950B (enExample)
CA (1) CA3090150A1 (enExample)
DK (1) DK3749669T6 (enExample)
ES (1) ES2946632T7 (enExample)
FI (1) FI3749669T6 (enExample)
TW (1) TWI840343B (enExample)
WO (1) WO2019156987A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11548867B2 (en) * 2017-07-19 2023-01-10 Idea Ya Biosciences, Inc. Amido compounds as AhR modulators
JP7382348B2 (ja) 2018-02-06 2023-11-16 アイディアヤ バイオサイエンシーズ,インコーポレイティド AhRモジュレータ
AU2020386967A1 (en) * 2019-11-22 2022-07-07 Sail Biomedicines, Inc. Pyridopyrimidinone derivatives as AHR antagonists
BR112022020965A2 (pt) * 2020-04-17 2022-12-06 Dong A St Co Ltd Derivados de piridopirimidinona e seu uso como moduladores de receptores de hidrocarboneto arila
US12570638B2 (en) 2020-05-20 2026-03-10 Sail Biomedicines, Inc. Fused imidazole derivatives as AHR antagonists
CN114181212B (zh) * 2020-09-15 2023-06-06 山东轩竹医药科技有限公司 哒嗪酮类AhR抑制剂
CN116745622A (zh) * 2020-10-13 2023-09-12 先达生物科技公司 与免疫检查点抑制剂疗法相关的生物标志物及其使用方法
US20230381182A1 (en) * 2020-10-13 2023-11-30 Senda Biosciences, Inc. Biomarkers Related to Immune Checkpoint Inhibitor Therapy and Methods of Using the Same
WO2023020512A1 (zh) * 2021-08-16 2023-02-23 成都奥睿药业有限公司 取代的吡啶类似物、其制备方法及作为ahr调节剂的用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU72201A (sh) 1999-04-28 2005-07-19 Aventis Pharma Deutschland Gmbh. Derivati di-aril kiseline kao ppar receptorski ligandi
JP2005504047A (ja) 2001-08-13 2005-02-10 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド 紫外線吸収剤
US20050256118A1 (en) 2004-05-12 2005-11-17 Altenbach Robert J Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
US7098222B2 (en) 2004-05-12 2006-08-29 Abbott Laboratories Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
US8410109B2 (en) 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
WO2008054599A2 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
CA2714181C (en) 2008-02-04 2013-12-24 Mercury Therapeutics, Inc. Ampk modulators
ES2586459T3 (es) 2008-05-01 2016-10-14 Glaxosmithkline Llc Quinolinas y análogos relacionados como moduladores de sirtuina
JP2011521958A (ja) * 2008-05-27 2011-07-28 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Wntタンパク質シグナル伝達阻害剤
MX2011009568A (es) 2009-03-09 2011-12-06 Surface Logix Inc Inhibidores de la rho cinasa.
WO2010148350A1 (en) * 2009-06-18 2010-12-23 Cornell University Photoproducts of tryptophan, their synthesis and uses thereof
AU2011282776B2 (en) * 2010-07-27 2014-06-12 Boston Medical Center Corporation Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
WO2012050500A1 (en) 2010-10-14 2012-04-19 Lars Pettersson 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環化合物及びその使用
AU2012212323A1 (en) 2011-02-01 2013-09-12 The Board Of Trustees Of The University Of Illinois HDAC inhibitors and therapeutic methods using the same
EP2788476B1 (en) 2011-12-08 2019-05-22 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
MX388871B (es) * 2014-06-27 2025-03-20 Nogra Pharma Ltd Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
US10669528B2 (en) 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
WO2017184547A1 (en) 2016-04-18 2017-10-26 New York University Quinoline compounds as modulators of rage activity and uses thereof
TWI674260B (zh) 2017-02-01 2019-10-11 德商菲尼克斯製藥股份有限公司 芳基烴受體(AhR)調節劑化合物
TWI752155B (zh) 2017-02-01 2022-01-11 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
TW201835070A (zh) 2017-02-21 2018-10-01 德商菲尼克斯製藥股份有限公司 芳香烴受體(AhR)調節劑化合物
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
US11548867B2 (en) 2017-07-19 2023-01-10 Idea Ya Biosciences, Inc. Amido compounds as AhR modulators
JP7382348B2 (ja) 2018-02-06 2023-11-16 アイディアヤ バイオサイエンシーズ,インコーポレイティド AhRモジュレータ
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds

Also Published As

Publication number Publication date
CA3090150A1 (en) 2019-08-15
JP2021512954A (ja) 2021-05-20
DK3749669T3 (da) 2023-06-06
US20230039955A1 (en) 2023-02-09
EP3749669B1 (en) 2023-03-08
TW201945362A (zh) 2019-12-01
US11407764B2 (en) 2022-08-09
FI3749669T6 (fi) 2024-11-13
WO2019156987A1 (en) 2019-08-15
EP3749669B3 (en) 2024-09-04
ES2946632T3 (es) 2023-07-21
FI3749669T3 (fi) 2023-05-26
EP4219495A1 (en) 2023-08-02
US12258354B2 (en) 2025-03-25
JP7382348B2 (ja) 2023-11-16
US20210002297A1 (en) 2021-01-07
CN111683950B (zh) 2024-04-16
EP3749669A1 (en) 2020-12-16
TWI840343B (zh) 2024-05-01
CN111683950A (zh) 2020-09-18
US20190270754A1 (en) 2019-09-05
US10815250B2 (en) 2020-10-27
ES2946632T7 (es) 2025-03-04

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
DK3743406T3 (da) Tmem16a modulatorer
EP3890716A4 (en) COMBINATION THERAPIES
EP3846674C0 (en) VAGINAL SPECULUM
EP3849534A4 (en) COMBINATION THERAPIES
EP3555124C0 (en) TCR NYESO
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
DK3749669T3 (da) Ahr-modulatorer
EP3899024A4 (en) Modulators of hsd17b13 expression
HUE062866T2 (hu) TREX-1 modulátorok
EP3781060A4 (en) CRYOPROBE
EP4101404C0 (en) INTRODUCTOR DEVICES
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
EP3809933A4 (en) Cleaner
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
EP3878374A4 (en) Occlusion device
EP3721129A4 (en) CRYOSPHERE
EP4025957C0 (en) ELECTRO-OPTIC MODULATOR
EP3779540A4 (en) Optical modulator
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem